| | | Articles | | Antibody Drug Conjugates in Reducing Disease Burden
Antibody Drug Conjugates provide a high level of promise, and hence there will be a conscious effort to expand the application(s) of this technology to disease indications beyond oncology provide a high level of promise, and hence there will be a conscious effort to expand the application of this technology to disease indications beyond oncology.... | Future Pharma
Pharmaceuticals play a critical role in improving human and animal health and well-being. They bring tremendous benefits to public health and economic productivity by saving lives, increasing life spans, reducing suffering, preventing surgeries, and even reducing hospital stays... | | Projects | | Merck Serono to invest €65 million for Biopharmaceutical R&D facility expansion in Germany
Merck Serono, the biopharmaceutical business of Merck, announced the expansion of its R&D facility in Darmstadt, Germany with an investment of €65 million.Merck is investing €65 million in a new laboratory building that will span more than 16,000 square meters and accommodate... | | Research Insights | | FARE-CAFE: a database of functional and regulatory elements of cancer-associated fusion events
Chromosomal translocation (CT) is of enormous clinical interest because this disorder is associated with various major solid tumors and leukemia. A tumor-specific fusion gene event may occur when a translocation joins two separate genes. Currently, various CT databases provide... | | |
Antibody Drug Conjugates
